The company’s brain-computer interface is implanted in a blood vessel on the brain’s surface and is designed to restore the capability for severely paralyzed patients to control devices with hands-free point-and-click, according to a Dec. 15 Synchron news release.
The financing will be used to launch a clinical trial.
ARCH Venture Partners led the financing, bringing Synchron’s total capital raised to $145 million.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
